Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066)

John B. Buse, Deborah J. Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A. D’Alessio, Melanie J. Davies

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

The incorrect figure legend was printed for Figure 2. The first sentence of the legend should read as follows: “Choosing glucose-lowering medication in those with indicators of high-risk or established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or heart failure (HF).” The online version of the article (https://doi.org/10.2337/dci19-0066) has been updated to correct this error.
Lingua originaleEnglish
pagine (da-a)1670-1670
Numero di pagine1
RivistaDiabetes Care
Volume43
DOI
Stato di pubblicazionePubblicato - 2020

Keywords

  • HYPERGLYCAEMIA
  • TYPE 2 DIABETES

Fingerprint

Entra nei temi di ricerca di 'Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066)'. Insieme formano una fingerprint unica.

Cita questo